Past studies of the association of vasectomy and prostate cancer have reported inconsistent results. Our objective was to investigate whether vasectomy and time since vasectomy are associated with a higher risk of prostate cancer. We conducted a cross-sectional study on unduplicated records of b 95 000 participants in a longitudinal study (1993±1995) of prostate cancer screening conducted during Prostate Cancer Awareness Week. Vasectomy was reported by 28%, and there were 2530 biopsies. w 2 tests and logistic regression analyses were used and found that vasectomy and an increased length of time since vasectomy are not associated with a higher risk of prostate cancer.
Introduction
Vasectomy is a highly reliable method of male contraception and has become widely accepted in both developed and developing countries. Studies indicate that this procedure has few adverse long-term physiologic effects on health. 1±5 Vasectomy does not alter plasma concentrations of testosterone (T), follicle stimulating hormone (FSH), or luteinizing hormone (LH); 6, 7 but it may be associated with higher serum dihydrotestosterone (DHT) levels among men who have been vasectomized 20 y. 7 Vasectomy has no effect on total prostate volume or the volume of the peripheral zone; 8, 9 but one study reported a signi®cant reduction in the volume of the periurethral zone three months after vasectomy. 9 Vasectomy may effect the prostate's secretory capacity, although reports are mixed. 2, 10 The issue of whether vasectomized men are at increased risk of prostate cancer would be of signi®cant public health concern, particularly in countries such as the United States where both vasectomy and prostate cancer are common. No known biological explanation for a possible link has been forthcoming, although some hypotheses have been offered. The production of antisperm antibodies in about half of vasectomized men led to speculation that a compromised immune system may be responsible for increased prostate cancer risk. 11 Giovannucci et al 12, 13 suggest a possible increased carcinogenic exposure as a result of the prostate's reduced secretory capacity after vasectomy. However, men regardless of vasectomy status experience less ejaculate as the prostate diminishes with age. Altered endocrine pro®les of men with vasectomy have recently been re-reported. 7, 14 However, no association has yet to be shown between higher serum levels of DHT and higher serum DHT/T ratios to DHT levels in the prostate, to prostatic carcinogenesis, or to more aggressive tumor behavior in man.
As the incidence of prostate cancer began to rise precipitously in the 1980s, etiological and risk factor analyses became of paramount importance, and a possible association of vasectomy and prostate cancer generated considerable interest. In addition to vasectomy alone being associated with a higher risk of prostate cancer, length of time since vasectomy has likewise been implicated.
Seven case-control studies 14±20 and seven cohort studies 1,5,12,13,21±23 have been published. Numerous reviews (listed in Reference 24), commentaries and methodological critiques 25±27 have appeared. Some studies have showed an association between having had a vasectomy and a diagnosis of prostate cancer, 12, 13, 16, 19, 20 but others have not.
14,15,17,21±23 One report of a positive association 18 later reversed its ®ndings. 28 Length of time between vasectomy and a diagnosis of prostate cancer has been more consistently reported as being associated with prostate cancer than vasectomy alone. The study of Honda et al 16 found the relative risk of prostate cancer was higher among men who had a vasectomy 30 y than among men who had no vasectomy or had a vasectomy less than 30 y. Hayes et al 20 reported a higher risk of prostate cancer for men having had a vasectomy 20 y. Mettlin et al 19 reported an increased risk for men who had a vasectomy 13±18 y prior to a diagnosis of prostate cancer but not among men who had a vasectomy 19±44 y prior. The most recent reports by Giovannucci et al 12, 13 similarly note this association. Their retrospective cohort study 13 found a signi®cantly increased relative risk of prostate cancer among men having a vasectomy 20 y prior to a diagnosis of prostate cancer. Their prospective cohort study 12 also reported that the strong association between vasectomy and an elevated risk of prostate cancer was even more pronounced among men who had their vasectomy 22 y in the past.
The present study is a cross-sectional analysis of a large cohort over a three-year period. The objective of a crosssectional study is to describe variables (vasectomy, time since vasectomy and prostate cancer), their distribution patterns and their associations. However, it does not have the long-term follow-up of a true cohort study. The large study population compensates in part for this shortcoming, all 95 961 of which reported vasectomy status. These men were participants in a longitudinal study of prostate cancer screening conducted in b 200 clinical centers throughout the US. All men provided institutional review board-approved informed consent to participate in the screening study. No other study of vasectomy and prostate cancer has used a screening population nor one of this size.
Material and methods
Unduplicated records (n 95 961) were assembled of participants in a longitudinal study of prostate cancer screening 1993±1995. The study was conducted as part of Prostate Cancer Awareness Week. Participants were tested with digital rectal examination (DRE) and prostate-speci®c antigen (PSA). Men with abnormal test results were directed to follow-up diagnostic testing to con®rm a diagnosis of prostate cancer. This longitudinal study and cohort have been previously described.
29±31
Only the most current record was retained for men who participated in more than one year. Only one record was included for each man biopsied, regardless of biopsy outcome. Age, vasectomy status, and year in which vasectomy was performed were self-reported. Biopsy results were reported by physicians to clinical centers.
Statistical analysis
Descriptive statistics were generated to characterize the study population by age, race, vasectomy status and biopsy result. The study population (95 961) was strati®ed by race and by age into 10 y age groups for those 40±79 y of age and one group for all 80 y of age. Time since vasectomy was strati®ed into three categories: 0±9 y prior to the most current record or biopsy; 10±19 y prior; and 20 y prior.
A series of w 2 tests were performed to examine the association of vasectomy and a diagnosis of prostate cancer in the entire biopsied population as well as within each age group. Regression analysis was used to substantiate w 2 results. Logistic regression models were formulated to analyze biopsy outcome as a function of age, vasectomy status, vasectomy status and length of time since vasectomy, and age and time since vasectomy. Separation of the cohort into age groups for these analyses allowed for age-adjustment when modeling on length of time since vasectomy.
To determine the relationship between prostate cancer and length of time since vasectomy adjusted for age, regression models were produced for each age group with three strata for time since vasectomy (0±9 y, 10± 19 y and 20 y since vasectomy). Biopsy outcome, positive or negative for prostate cancer, was modeled as a variable whose value was dependent upon vasectomy status.
Strati®cation by time since vasectomy was assigned by participants' self-reported year in which vasectomy was performed. Analysis of all records produced coef®cients for each strata of time since vasectomy and re¯ected the probability of biopsy outcome as a function of these states.
All tests were performed using SAS # program software. 32 
Results
The mean age of the study population (95 961) was 61.7 AE 8.0 y (range 40±95). Eleven per cent was between 40±49 y of age, and 67% between the ages of 50±69 y. Twenty-two per cent was aged 70 y, and 2.5% was 80 y of age. The vast majority was Caucasian (91.1%). Blacks comprised 5.3% of the cohort; Latinos and Asians each represented less than 2%.
Twenty-eight percent reported having had a vasectomy. The mean age of all vasectomized men (59.4 AE 8.5) was signi®cantly lower than that of non-vasectomized men (62.8 AE 9.8) (Wilcoxon rank sum, P 0.0001). However, no such difference in mean ages was found when the population was divided into 10 y age groups. Men aged 50±59 y reported the highest rates of vasectomy (35.7%), and men aged b 80 y reported the lowest rates (10.4%) (Figure 1 ). Vasectomy rates were highest among whites (29%); blacks (n 5081) reported only an 8.6% vasectomy rate ( Figure 2 ). The mean time since vasectomy was 20 y, but it increased linearly as age increased (Table 1 ). 
In this cohort of 95 961 men, the 2530 biopsies reported represent a 2.6% biopsy rate. Not all men with abnormal, suspicious test results went to biopsy. However, a test of proportions showed that there was no difference in follow-up compliance/non-compliance between men with and without vasectomy (P 0.077). There were 766 (30.3%) positive and 1764 negative biopsies. Mean time since vasectomy for men who biopsied positive (22.1 y) did not differ signi®cantly (P 0.6) from that for men with negative biopsies (21.1 y). For the entire biopsied population (n 2530) no statistically signi®cant association was observed between vasectomy and a positive biopsy (w 2 P 0.5; OR, 0.93; 95% CI, 0.77±1.14). A series of w 2 tests were performed to assess the association of vasectomy and a diagnosis of prostate cancer within each age group. Observed and expected biopsies by age group and vasectomy status are found in Table 2 . No statistically signi®cant difference was found in any age group between vasectomy status and biopsy result. Although w 2 tests determined an insigni®cant relationship between vasectomy and biopsy result for the entire study population as well as for each age group, regression analysis tested biopsy result against vasectomy alone and substantiated the w 2 tests (P 0.49, OR 1.071) ( Table 3) . A linear regression model for all subjects resulted in a signi®cant correlation between age and time since vasectomy (r 0.307, F 67.195, P 0.0001), demonstrating that older men had been vasectomized for longer periods of time. By logistic regression analysis age alone was signi®cantly associated with a diagnosis of prostate cancer (P 0.0001, OR 1.03; 95% CI, 1.02±1.04). When age and time since vasectomy were modeled together, age retained its signi®cant association but time since vasectomy was not found to be signi®cantly associated with a diagnosis of prostate cancer (P 0.78; OR 1.0; 95% CI, 0.98±1.01).
Logistic regression modeling for all men biopsied showed that vasectomy was not associated with a diagnosis of prostate cancer regardless of time since vasectomy: 0±9 y (P 0.541; OR 0.76, 95% CI, 0.31±1.84); 10± 19 y (P 0.157; OR 1.613, 95% CI, 0.832±3.127); 20 y (P 0.933; OR 1.025, 95% CI, 0.580±1.809).
Logistic analysis substantiated the ®nding that time since vasectomy was not a signi®cant risk factor for prostate cancer (P 0.941, OR 1.00 [95% CI; 0.993± 1.008]) (Table 4) . When the population was subdivided into age groups, logistic regression models using three categories of time since vasectomy resulted in no statistical signi®cant association between time since vasectomy and a diagnosis of prostate cancer for the 50±59 and 60± 69 y age group (Table 5 ). The models failed to determine valid coef®cients for the 40±49, 70±79, and !80 y age groups, and regression analysis results were unobtainable. To obtain coef®cients for the 70±79 y age group the regression model was modi®ed to include only two periods of time since vasectomy, 0±19 y and 20 y. Analysis with this model showed no signi®cance association between biopsy result and time since vasectomy for the two time periods among 70±79 y olds. If risk of prostate cancer is not a function of time since vasectomy, as indicated in the 50±59, 60±69, and 70±79 y age groups, the inability to obtain coef®cients for the two less populous age groups (40±49, n 10 322; !80, n 2391) may be due to the coef®cients having a true value of zero in these populations.
Discussion
In this cross-sectional analysis of b 95 000 men in a longitudinal study of prostate cancer screening, no positive association was found between either vasectomy or time since vasectomy and prostate cancer based on 2530 biopsies. This analysis has obvious strengths and limitations. A cross-sectional design maximizes the value of a large (b 95 000) population that was accrued to participate in the same study. The time period (1993±1995) was one characterized by considerable public awareness of both prostate cancer and the possible association of vasectomy and prostate cancer because of the publication of the two Giovannucci et al 12, 13 reports of a positive association during the peak of PSA testing in the US. Certainly, the percentage of vasectomized men in this study is representative of recently estimated rates in the US 14 and considerably higher in each 10 y age group than prevalence rates established in 1990. 25 It is possible that vasectomized men were more likely to participate in prostate cancer screening during these years because of a perceived risk from vasectomy. Previous case-control studies 18, 19 have been criticized because of low vasectomy prevalence rates among controls. 25±27 If there is selection bias in the current study, it should con®rm our ®ndings more conclusively.
The longitudinal study from which this analysis was conducted was designed to examine prostate cancer detection among asymptomatic men, and risk factors, for example vasectomy were identi®ed a priori. However, all medical history data are self-reported and no veri®ca-tion of vasectomy was possible in this large population of men. The most signi®cant limitation of this analysis, as with the larger longitudinal study, is the less-than-optimal rate of participant follow-up after abnormal DRE or elevated PSA and the resultant low biopsy rate.
In this cross-sectional analysis of more than 95 000 men, no association was found between either vasectomy or time since vasectomy and prostate cancer. The study concurs with others 14,15,16,17,21 ± 23 that found no elevated risk of prostate cancer among men with vasectomy. It disputes ®ndings 12, 13, 16, 19, 20 that the risk of prostate cancer increases with length of time since vasectomy.
The controversy regarding a possible association between length of time since vasectomy and an increased prostate cancer risk began with the population-based case-control study (216 matched pairs) of Honda et al. 12 This study found an increasing risk of prostate cancer Bx positive biopsy; 7Bx negative biopsy; Obs observed; Exp expected; n number; P probability; OR odds ratio; CI con®dence interval; Vas reported vasectomy, ÀVas reported no vasecetomy.
among married men as time since vasectomy increased (trend, P 0.01); but ®ndings were quali®ed by the lack of representativeness among both cases and controls. The population based case-control study (965 matched pairs) conducted by Hayes et al 20 reported an increased risk for men who had a vasectomy 20 y prior to prostate cancer diagnosis and an increased risk for men who were vasectomized`35 y of age. The hospital-based case-control study of Mettlin et al 19 reported ambiguous results: a higher risk for men who had a vasectomy 13±18 y before a diagnosis of prostate cancer but no risk for men who had a vasectomy 5±12 or 19±44 y before a diagnosis of prostate cancer. These ®ndings suggest more a chance association rather than a reinforcement of the linear relationship suggested by the ®ndings of Honda et al 16 that risk increased as time lengthened between vasectomy and prostate cancer diagnosis. Both cohort studies of Giovannucci et al 12, 13 found an increasing relative risk of prostate cancer as time since vasectomy increased. This association held in both studies after limiting cases to stages C and D cancers, 104 and 16 cases respectively. A strength of these studies (large cohorts) can actually represent a potential weakness, ®nding statistical signi®cance without clinical signi®cance.
In this cross-sectional analysis of b 95 000 men, time since vasectomy was not associated with a higher risk of prostate cancer. Odds ratios did not vary signi®cantly in any age group regardless of strata of time since vasectomy. There was no tendency for the odds ratio estimate to increase as the time interval since vasectomy increased.
Perhaps, in this particular analysis the salient ®nding is that when two continuous variablesÐage and time since vasectomyÐare combined in regression analysis, any signi®cance of time since vasectomy is cancelled by age, which remains the single greatest risk factor for prostate cancer.
Conclusions
Biologic mechanisms whereby vasectomy, time since vasectomy, and aging itself may increase a man's risk of prostate cancer remain unknown. No relevant clinical data have been reported to elucidate these factors. Findings from the present study support the contention that vasectomy and increased length of time since vasectomy do not increase the risk of prostate cancer. 
